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Fig. S1 Skeletal structures of thiol bearing ligands used for capping reaction to 
generate gold nanoparticle monolayer with azide functionality. a) CVVVT-ol 
peptidol, b) alkane thiol polyethylene glycol (HS-C11-(EG)4-OH) and c) alkane thiol 
polyethylene glycol bearing an azide group at the terminus (HS-C11-(EG)5-N3).	   	  
	  	  
 
Fig. S2 Calculated stability parameter for a) mix-matrix and b) 1 % N3 NPs in the 
presence of DTT. The stability parameter was taken at time points of 1 h (◆), 3 h (■), 
6 h (▲), 24 h (✕) and 48 h (✳). The stability parameter was measured and calculated 
exactly as described by Chen et al.1, i.e., the absorbance at  650 nm (minus the 
reference of ddH20) divided by the absorbance at 520 nm (again minus the reference 
of ddH20).  The calculated values were then normalised to the stability parameter 
calculated for capped nanoparticles in the absence of DTT at each time point. Here 
the stability parameter demonstrates that there is no significant exchange of ligands 
on the nanoparticles for DTT occurring up to 3 h at all concentrations and up to 10 
mM over 24 h and 48 h. 	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Fig. S3 Reaction scheme for DIBO-Mal with azide functionalised gold nanoparticles.  
The DIBO-Mal simultaneously acts as both a nucleophile and electrophile, attacking 
the azide functional group in the nanoparticle monolayer.  This leads to the pericyclic 
formation of a triazole, thus installing maleimide functionality to the monolayer 
(blue). 
 
 	   	  
Au Au 
	  	  	  	  	  	  	  	  	  
 
 
Fig. S4 Schematic of predicted three-dimensional structure of FGF-2 derived from 
PBD 1BFF 2 using PyMol. The structure of FGF-2 is represented in both ribbon (a) 
and electrostatic surface (b) forms.  The cysteines present within FGF-2 are denoted 
in the amino acid sequence (pink, bottom).  All cysteines in FGF-2 are denoted in (a), 
whereas only the cysteines with solvent exposed thiol side chains are visible in (b) 
and ringed in both structures (black). The most exposed cysteine, C-95, and a 
candidate for Michael addition to the nanoparticle is marked with the arrow (red).  
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Fig. S5 Heparin affinity chromatography of Mal-NPs mixed with blocked FGF2 
protein.  The surface thiols of FGF2 were reacted with a molar excess of biotin-
maleimide (N-Biotinoyl-N'-(6-maleimidohexanoyl)hydrazide; Sigma Aldrich) prior to 
incubation with Mal-NPs.  Removal of excess biotin-maleimide was achieved by 
heparin affinity chromatography of FGF2 and washing with 3 column volumes of 
PBST0.05%.  Blocked FGF2 was then eluted from the column with 2 M NaCl. Te 
blocked FGF2 was then incubated in a molar excess over Mal-NPs for 3 h with 
mixing on a wheel.  The mixture was then passed through a heparin affinity column, 
and washed with 3 column volumes of PBST0.05%.  No Mal-NPs bound the column 
indicating that the thiol-Michael addition reaction with FGF2 was prevented due to 
the prior blocking step.	   	  
	  	  
Fig. S6 Exemplar reaction scheme for thiol-Michael addition reaction between 
maleimide functionalised gold nanoparticles and dithiothreitol (DTT). The double 
bond of the maleimide is attacked by a nucleophillic thiol group of DTT.  This leads 
to the formation of a stable thioether bond, which in the case of DTT yields a free, 
external of the monolayer (blue), thiol group for further thiol-Michael reactions	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Fig. S7 Anion-exchange chromatography of the products from the reaction of MPBH 
(4-(4-N-Maleimidophenyl)butyric acid hydrazide-HCl; Thermo Fischer Scientific 
Inc., Rockford, IL, USA) and heparin-derived oligosaccharide degree of 
polymerisation (dp) 12 in formamide. Analysis of the products of the reaction of 
MPBH (15 mg/mL) and dp12 (1 mg) in formamide using anion-exchange 
chromatography (230 nm) using a HiTrap Q column (1 mL) equilibrated with HPLC 
grade water (Fisher Scientific, Loughborough, UK).  After loading the sample, the 
column was developed with a gradient of 2 M NaCl in the same buffer at a flow rate 
of 1 mL/min (----).  The dp12 control (----): 100 µL of 1 mg freeze-dried dp12 in 
HPLC grade water. MPBH control (••••): 100 µL of 15 mg/mL MPBH dissolved in 
formamide with 2.5 µL of acetic acid and 400 µL of HPLC grade water. MPBH and 
dp12 reaction product (—): dissolved in 400 µL HPLC grade water.  
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Table S1 Compound purity of porcine intestinal mucosal heparin.  
 
The starting material for all chemical modifications was porcine intestinal 
mucosal heparin (CelsusLabs, Cincinnati, OH, USA; lot PH-42800 with anticoagulant 
activity 201 IU.mg-1). 
The polysaccharide was subjected to purification by size-exclusion 
chromatography (Sephadex G-25, recovering only the exclusion limit; Mw> 5 KDa) 
and treated with ion exchange resin (Dowex, W-50, Na+ form) prior to NMR and 
activity testing. 
Size-exclusion chromatography analysis of the polysaccharide was also 
conducted with a TSK gel G2000SWXL column (7.8 mm x 30 cm with 0.5 µm 
particle size; Supelco) eluting with water at 1 mL/min and detecting at 190 nm. All 
the samples exhibited a single major peak (>95 %), with very similar retention times 
(mean, 6.07 minutes; Dn-1=0.05). 
Porcine mucosal heparin was also exhaustively digested with a mixture of 
heparitinases I, II and III to their constituent disaccharides (here denoted 1 to 8). 
Disaccharides were separated by strong-anion exchange HPLC (Propac PA-1 column, 
Dionex UK) and quantified (A232) with reference to authentic standards (Dextra 
Labs, Reading, UK) and showed the following composition (%). In all cases, 
unidentified peaks were < 5% of the total area of the constituents3. 
 
 
 
 Disaccharide ✢ 
Porcine 
Mucosal 
Heparin 
1 2 3 4 5 6 7 8 
6.8 - 3.4 13.4 7.0 67.4 - 8.0 
 
 
✢ Standards: 1, ΔUA-GlcNAc; 2, ΔUA-GlcNAc(6S); 3, ΔUA-GlcNS; 4, ΔUA-
GlcNS(6S); 5, ΔUA(2S)-GlcNS; 6, ΔUA(2S)-GlcNS(6S); 7, ΔUA(2S)-GlcNAc and 
8, ΔUA(2S)-GlcNAc(6S), where GlcNAc is N-acetyl glucosamine, ΔUA is the uronic 
acid (glucuronate or iduronate, which cannot be distinguished), 6S and 2S refer to 
ester O-sulfates on the respective carbon of the sugar, NS to the amino sugar on C2 of 
the glucosamine. 
  
Table S2 1H and 13C NMR chemical shift values for porcine intestinal mucosal 
heparin. 
 
The porcine mucosal heparin was characterized by 1H and 13C NMR to confirm its 
structure. NMR spectra were recorded in D2O at 40 °C on a 400 MHz instrument. 
Assignment was by a combination of COSY, TOCSY, HMBC two-dimensional 
spectra. 13C spectra were recorded on 150 mg samples of the heparin. Chemical shift 
values were recorded relative to trimethylsilyl propionate as reference standard at 40 
°C3. 
 
 
 
 Glucosamine   Iduronate 
 A-1 A-2 A-3 A-4 A-5 A-6  I-1 I-2 I-3 I-4 I-5 
Porcine 
Mucosal 
Heparin 
99.5 60.7 72.5 78.8 72.0 69.2  102.1 78.9 72.1 79.0 72.3 
5.42 3.31 3.69 3.79 4.05 4.30-4.42  5.23 4.37 4.22 4.14 4.82 
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